Front Row Advisors’s Alkermes ALKS Stock Holding History

Front Row Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-73	Closed	-$3	–	981
2018 Q2	$3	Hold	73	–	–	﹤0.01%	724
2018 Q1	$4K	Buy	+73	New	+$4.27K	﹤0.01%	601

Other funds holding ALKS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Front Row Advisors's ALKS Position: Q3 2018 in Review

Front Row Advisors sold out of Alkermes (ALKS) in Q3 2018, closing a stake of 73 shares — an estimated $3 sold.

Front Row Advisors first reported a position in ALKS in Q1 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2018. 261 funds tracked by Wall St. Rank hold ALKS as of Q3 2018.

Front Row Advisors reported no remaining Alkermes position as of Q3 2018 after selling out during the quarter.
Front Row Advisors sold 73 Alkermes shares in Q3 2018, an estimated $3.
Front Row Advisors first reported a position in Alkermes in Q1 2018 and held it in 2 quarters.
Front Row Advisors's Alkermes position peaked at $4K in Q1 2018.
261 funds tracked by Wall St. Rank held Alkermes as of Q3 2018.

Based on Front Row Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.